Molecular Modelling of Berberine Derivatives as Inhibitors of Human Smoothened Receptor and Hedgehog Signalling Pathway Using a Newly Developed Algorithm on Anti-Cancer Drugs-Reference-Cited by-同舟云学术

Molecular Modelling of Berberine Derivatives as Inhibitors of Human Smoothened Receptor and Hedgehog Signalling Pathway Using a Newly Developed Algorithm on Anti-Cancer Drugs

Published:2017-11-20 Issue:4 Volume:12 Page:
ISSN:1574-8928
Container-title:Recent Patents on Anti-Cancer Drug Discovery
language:en
Short-container-title:PRA

Author:

Kaboli Parham Jabbarzadeh¹,Bazrafkan Mohammad²,Ismail Patimah¹,Ling King-Hwa¹

Affiliation:

1. Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia

2. Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padua, Italy

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Cancer Research,Drug Discovery,Oncology,General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berberine suppresses colorectal cancer by regulation of Hedgehog signaling pathway activity and gut microbiota;Phytomedicine;2022-08

2. Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress;Gene;2022-03

3. A rational in silico approach to identify inhibitors of Batroxrhagin from Bothrops atrox;Journal of Biomolecular Structure and Dynamics;2021-06-01

4. Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy;Seminars in Cancer Biology;2020-05

5. Identification of novel inhibitors of signal transducer and activator of transcription 3 over signal transducer and activator of transcription 1 for the treatment of breast cancer by in-silico and in-vitro approach;Process Biochemistry;2019-07